Septerna (SEPN) Gains from Sales and Divestitures (2024 - 2026)

Septerna's quarterly Gains from Sales and Divestitures came in at $55977.0 in Q1 2026, down 53.25% year-on-year from $119730.0 in Q1 2025, and down 87.36% quarter-over-quarter from $442993.0 in Q4 2025.

Septerna has reported Gains from Sales and Divestitures for 3 years, with the latest figure at $55977.0 in Q1 2026.

  • For the quarter ending Q1 2026, Gains from Sales and Divestitures fell 53.25% year-over-year to $55977.0; the trailing twelve-month figure through Mar 2026 stood at $55977.0 (down 53.25% YoY), and the FY2025 full-year result was $442993.0, up 7.81% from the prior year.
  • Gains from Sales and Divestitures for Q1 2026 stood at $55977.0, down from $442993.0 in the prior quarter.
  • The five-year high for Gains from Sales and Divestitures was $442993.0 in Q4 2025, with the low at $55977.0 in Q1 2026.
  • Average Gains from Sales and Divestitures over 3 years is $266059.1, with a median of $251493.0 recorded in 2024.
  • Year-over-year, Gains from Sales and Divestitures jumped 37.66% in 2025 and plunged 53.25% in 2026.
  • Tracing SEPN's Gains from Sales and Divestitures over 3 years: stood at $410916.0 in 2024, then climbed by 7.81% to $442993.0 in 2025, then sank by 87.36% to $55977.0 in 2026.
  • The last three Gains from Sales and Divestitures figures came in at $55977.0 (Q1 2026), $442993.0 (Q4 2025), and $346197.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Septerna 1.34 Bn 1.34 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 55,977.00
Mar 31, 2026 55,977.00
Dec 31, 2025 442,993.00
Dec 31, 2025 442,993.00
Sep 30, 2025 346,197.00
Sep 30, 2025 346,197.00
Jun 30, 2025 235,108.00
Jun 30, 2025 235,108.00
Mar 31, 2025 119,730.00
Mar 31, 2025 119,730.00
Dec 31, 2024 410,916.00
Dec 31, 2024 410,916.00
Sep 30, 2024 251,493.00
Sep 30, 2024 251,493.00